Verition Fund Management LLC Immunity Bio, Inc. Transaction History
Verition Fund Management LLC
- $19.9 Billion
- Q1 2025
A detailed history of Verition Fund Management LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 827,039 shares of IBRX stock, worth $2.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
827,039
Previous 50,330
1543.23%
Holding current value
$2.4 Million
Previous $128,000
1844.53%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IBRX
# of Institutions
238Shares Held
79.9MCall Options Held
1.08MPut Options Held
2.73M-
Vanguard Group Inc Valley Forge, PA20.3MShares$59 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$33.1 Million0.0% of portfolio
-
State Street Corp Boston, MA7.58MShares$22 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.29MShares$12.4 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.45MShares$9.99 Million0.07% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.16B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...